文献速递乳腺外科

单期ADM乳房重建与两期扩张器-假体重建的短期成本效果:多中心随机临床试验

Short-term cost-effectiveness of one-stage implant-based breast reconstruction with an acellular dermal matrix versus two-stage expander-implant reconstruction from a multicentre randomized clinical trial.
PubMed 文献 · Br J Surg · 2019-03-05

BRIOS多中心随机对照试验比较了保留皮肤乳房切除后即刻单期ADM乳房重建与两期扩张器-假体重建的经济性。结果显示单期ADM组手术时间更长、费用更高,但术后健康状态无差异。

要点

  • 单期ADM乳房重建费用高于两期重建,单侧和双侧均如此
  • 单期ADM组手术时间显著长于两期组
  • 两组术后健康状态评分无差异

核心结论

  • 单期ADM乳房重建相比两期重建费用更高但健康状态相似。

研究设计与样本

  • BRIOS研究为开放标签多中心随机对照试验,纳入拟行保留皮肤乳房切除和即刻植入物乳房重建的女性。

主要发现

  • 两组术后健康状态无差异。

临床怎么用

  • 在决策单期ADM与两期乳房重建时,需权衡更高的费用与相似的健康状态。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Implant-based breast reconstruction (IBBR) is the most commonly performed reconstructive procedure and its economic impact is significant. This study aimed to analyse whether a direct one-stage IBBR with use of an acellular dermal matrix (ADM) is more cost-effective than two-stage (expander-implant) breast reconstruction. METHODS: The BRIOS (Breast Reconstruction In One Stage) study was an open-label multicentre RCT in which women scheduled for skin-sparing mastectomy and immediate IBBR were randomized between one-stage IBBR with ADM or two-stage IBBR. Duration of surgery and hospital stay, and visits for the primary surgery, unplanned and cosmetic procedures were recorded. Costs were estimated at an institutional level. Health status was assessed by means of the EuroQol Five Dimensions 5L questionnaire. RESULTS: Fifty-nine patients (91 breasts) underwent one-stage IBBR with ADM and 62 patients (92 breasts) two-stage IBBR. The mean(s.d.) duration of surgery in the one-stage group was significantly longer than that for two-stage IBBR for unilateral (2·52(0·55) versus 2·02(0·35) h; P < 0·001) and bilateral (4·03(1·00) versus 3·25(0·58) h; P = 0·017) reconstructions. Costs were higher for one-stage compared with two-stage IBBR for both unilateral (€12 448 (95 per cent c.i. 10 722 to 14 387) versus €9871 (9373 to 10 445) respectively; P = 0·025) and bilateral (€16 939 (14 887 to 19 360) versus €13 383 (12 414 to 14 669); P = 0·002) reconstructions. This was partly related to the use of relatively expensive ADM. There was no difference in postoperative health status between the groups. CONCLUSION: One-stage IBBR with ADM was associated with higher costs, but similar health status, compared with conventional two-stage IBBR. Registration number: NTR5446 ( http://www.trialregister.nl).

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Negenborn VL, Smit JM, Dikmans REG, et al. Short-term cost-effectiveness of one-stage implant-based breast reconstruction with an acellular dermal matrix versus two-stage expander-implant reconstruction from a multicentre randomized clinical trial. Br J Surg. 2019. PMID: 30835827. doi:10.1002/bjs.11102

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。